1 citations
,
April 2022 in “Journal of Biological Regulators and Homeostatic Agents/Journal of Biological Regulators & Homeostatic Agents” This study reported that among 1337 patients receiving biocompatible artificial hair implants, common side effects included mild inflammation (7%) and itching (<3%), while patient satisfaction was high at 96%, though COVID-19 may have impacted some results.
December 2025 in “Frontiers in Medicine” This study assessed patient satisfaction and hair retention in 15 individuals with alopecia treated with Biofibre ® 4.0 artificial hair implants, finding high levels of satisfaction and excellent biocompatibility, with no significant adverse reactions reported after one year.
3 citations
,
June 2019 in “Dermatologic Therapy” This study reported that the Biofibre® hair implantation system, used on 1,518 patients with various degrees of baldness and causes of alopecia, delivered immediate and visible results without scarring or hospitalization, which greatly improved patients' self-esteem and psychological well-being.
7 citations
,
December 2017 in “Open Access Macedonian Journal of Medical Sciences” This abstract outlines the historical development and medical validation of artificial hair implants, particularly the approval and improvement of the Biofibre® implant technique in Europe and Australia, and highlights its advantages as the latest advancement in hair restoration treatments.
3 citations
,
January 2018 in “Open Access Macedonian Journal of Medical Sciences” In this study, the use of Biofibre hair implants showed significant improvements in scalp coverage and Hamilton scale grading for 97.94% of male and female patients with androgenetic alopecia after two years, with minimal and manageable side effects reported.
